mononuclear cells in every leukopak
< 48 hours
from collection to delivery
viability of fresh leukopaks
Overview: Experience the confidence of Discovery Leukopaks™
Choosing Discovery means choosing confidence.
Phrases like single chain of custody, our own donor recruiting team, and in-house collection and processing facilities may not sound exciting, but the difference they make in the quality of our leukopaks is enormous. It’s all about the amount of insight and control we have from donor selection to shipped leukopak. Through small tweaks and optimizations at every stage of the process, we have built unparalleled excellence, reliability, and quality into our fresh leukopaks.
We have 2,800+ recallable donors that can support your research with consistent materials.
We can start collections within 2 – 14 days of receiving your purchase order, and provide same-day or next-day delivery, depending on your location.
We maintain a single chain of custody – from collection and leukapheresis to characterization and distribution of leukopaks to our clients. This affords consistent, rigorous quality control measures throughout and improves donor recallability via well-established donor relationships.
With the recent addition of our on-site GMP collection facility, you have the potential to use the same donors in research and clinical development/manufacturing, maximizing the efficiency and predictability of your operations.
In addition to the typical donor demographic information and infectious disease testing one would expect, we routinely HLA type all donors to 6-digit resolution using NGS.
We are FDA Licensed for Blood Products, GMP/GLP compliant, CLIA Registered and CAP registered with accreditation pending
Advanced Analysis and Cell Processing
The FDA licensed GMP Collection facility is housed in the same building as our Cell Processing, Flow Cytometry and our HudsonAlpha Discovery Genomics Center, which provides highly sophisticated analyses and high quality data meeting our customers’ turnaround time needs.
CONSULTATIVE CELL SERVICES
READY FOR GMP-GRADE LEUKOPAKS?
Discovery Fresh Leukopaks are manufactured from the peripheral blood of normal human donors at our wholly owned and operated US Donor Center. Each Discovery Fresh Leukopak consists of a concentrated fraction of mononuclear cells including:
EACH DISCOVERY CRYO LEUKOPAK (RUO) CONSISTS OF A CONCENTRATED FRACTION OF MONONUCLEAR CELLS INCLUDING:
- B cells
- Dendritic cells
- T cells
- NK cells
All cells are obtained using IRB approved consent forms and protocols. Each donor is tested for HIV, HBV, HCV, and CMV, and HLA typed via 6-digit NGS. Additional characterization can be performed—please inquire.
RESEARCH USE ONLY. NOT INTENDED FOR CLINICAL USE.
|Discovery Fresh Leukopaks (RUO)||Product No.||Total Cell Count||List Price*|
|78023||9.5 Billion Minimum||$3,120|
|Half Leukopak||53678||5 Billion Minimum||$2,080|
|Quarter Leukopak||75663||2.5 Billon Minimum||$1,716|
|Custom Order||C-5672||Custom||Contact Us for Pricing|
* Pricing may vary depending on your project specific details. Contact us for project specific pricing.
All cells are obtained using IRB approved consent forms and protocols.
We perform extensive characterization of all donors that includes:
- Smoking status
- Blood type
HLA-typing to 6-digit resolution with NGS
Virus Testing Every 90 Days
- Hepatitis B Core Antibody (Anti-HBc EIA)
- Hepatitis C Virus Antibody (Anti-HCV EIA)
- Human Immunodeficiency Virus Antibody (HIV 1/2 plus O)
- Additional tests can be performed—please inquire.
Example of a
Related Products & Services:
Discovery Life Sciences also offers GMP compliant Discovery Fresh Leukopaks, Discovery Fresh Leukopaks™ (RUO) and cryopreserved, primary immune cell isolates which are produced from Discovery Fresh Leukopaks, with the ability to begin all cell isolation protocols within 1 hour of leukapheresis.
Frequently Asked Questions
Where are your sites?
Your samples are all from healthy, normal donors—how do you define “normal"?
For a donor to qualify as normal, they cannot be currently diagnosed or have a history of cancer, autoimmune disease, or any major comorbidity (i.e. diabetes, high blood pressure, etc.). Contact us to learn more.
How do you facilitate the transition between RUO and GMP?
Our integrated project management approach facilitates the transition between research and clinical phases. Client-specific donor pools provide premier access and flexibility for GMP and RUO collections.
Has COVID-19 affected your collection, processing, and/or analytical facilities?
How often can you perform apheresis on a specific donor?
What anticoagulant do you use for Discovery Leukopaks™?
Which collection protocol/program and consumable sets are you using?
To propel your projects with The Power of Discovery.™
Contact Us Today
Let us know about your project!